Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Carcinoma, Renal Cell × Denosumab × Clear all

Phase

Phase 2 2 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 9 Prostatic Neoplasms 6 Neoplasms 6 Multiple Myeloma 4 Fractures, Bone 4 Osteoporosis 3 Bone Diseases, Metabolic 3 Spinal Cord Compression 2 Giant Cell Tumor of Bone 2 Bone Diseases 2 Parathyroid Neoplasms 1 Paraproteinemias 1 Neoplastic Processes 1 Neoplasms, Plasma Cell 1 Neoplasm Metastasis 1 Multiple Endocrine Neoplasia Type 1 1 Mastocytosis, Systemic 1 Lymphoma 1 Hyperparathyroidism, Primary 1 Hormone Refractory Prostate Cancer 1 Hematologic Neoplasms 1 Hematologic Diseases 1 Cataract 1 Castrate-resistant Prostate Cancer 1 Carcinoma, Renal Cell 1 Carcinoma 1 Breast Diseases 1 Bone Neoplasms 1 Bone Metastases From Solid Tumors 1 Bone Metastases 1

Interventions

Sunitinib 17 Nivolumab 13 pembrolizumab 10 Sorafenib 10 pazopanib 9 cabozantinib 9 Interferon-alpha 9 Everolimus 8 Ipilimumab 7 Bevacizumab 7 belzutifan 6 aldesleukin 6 lenvatinib 5 Magnetic Resonance Spectroscopy 5 Axitinib 5 atezolizumab 4 temsirolimus 3 Radiosurgery 3 Nephrectomy 3 Interferon alpha-2 3 tivozanib 2 durvalumab 2 avelumab 2 Specimen Handling 2 Saline Solution 2 Interleukin-2 2 G250 monoclonal antibody 2 Fluorouracil 2 Chemotherapy, Adjuvant 2 1-(1-(imidazo(1,2-a)pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-(1,2,3)triazolo(4,5-b)pyrazine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03408652 2021-10-22

MOSCAR

Centre Leon Berard

Phase 3 Terminated

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡